IMM 1.49% 34.0¢ immutep limited

NRT's drug will be in competition with current forms of...

  1. 63 Posts.
    NRT's drug will be in competition with current forms of chemotherapy. CVac is a maintenance therapy post chemo. So even if nrt does make it to market there is no direct competition anyway.
 
watchlist Created with Sketch. Add IMM (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.